These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 33526455)

  • 1. The Cell Biology of LRRK2 in Parkinson's Disease.
    Usmani A; Shavarebi F; Hiniker A
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33526455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease.
    Xiong Y; Dawson VL; Dawson TM
    Biochem Soc Trans; 2012 Oct; 40(5):1074-9. PubMed ID: 22988868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for Parkinson's disease-linked LRRK2's binding to microtubules.
    Snead DM; Matyszewski M; Dickey AM; Lin YX; Leschziner AE; Reck-Peterson SL
    Nat Struct Mol Biol; 2022 Dec; 29(12):1196-1207. PubMed ID: 36510024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
    Stormo AED; Shavarebi F; FitzGibbon M; Earley EM; Ahrendt H; Lum LS; Verschueren E; Swaney DL; Skibinski G; Ravisankar A; van Haren J; Davis EJ; Johnson JR; Von Dollen J; Balen C; Porath J; Crosio C; Mirescu C; Iaccarino C; Dauer WT; Nichols RJ; Wittmann T; Cox TC; Finkbeiner S; Krogan NJ; Oakes SA; Hiniker A
    J Cell Biol; 2022 Apr; 221(4):. PubMed ID: 35266954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.
    Komori T; Kuwahara T
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
    Lee CY; Menozzi E; Chau KY; Schapira AHV
    J Neurochem; 2021 Dec; 159(5):826-839. PubMed ID: 34618942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes.
    Unapanta A; Shavarebi F; Porath J; Shen Y; Balen C; Nguyen A; Tseng J; Leong WS; Liu M; Lis P; Di Pietro SM; Hiniker A
    J Biol Chem; 2023 Oct; 299(10):105192. PubMed ID: 37625589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease.
    Seol W
    BMB Rep; 2010 Apr; 43(4):233-44. PubMed ID: 20423607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 and mitochondria: Recent advances and current views.
    Singh A; Zhi L; Zhang H
    Brain Res; 2019 Jan; 1702():96-104. PubMed ID: 29894679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 Structure-Based Activation Mechanism and Pathogenesis.
    Zhang X; Kortholt A
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease.
    Ito G; Utsunomiya-Tate N
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 and autophagy: a common pathway for disease.
    Manzoni C
    Biochem Soc Trans; 2012 Oct; 40(5):1147-51. PubMed ID: 22988880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the focal role of LRRK2 kinase in Parkinson's disease.
    Kumar S; Behl T; Sehgal A; Chigurupati S; Singh S; Mani V; Aldubayan M; Alhowail A; Kaur S; Bhatia S; Al-Harrasi A; Subramaniyan V; Fuloria S; Fuloria NK; Sekar M; Abdel Daim MM
    Environ Sci Pollut Res Int; 2022 May; 29(22):32368-32382. PubMed ID: 35147886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 phosphorylation of Rab GTPases in Parkinson's disease.
    Pfeffer SR
    FEBS Lett; 2023 Mar; 597(6):811-818. PubMed ID: 36114007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation.
    Fasiczka R; Naaldijk Y; Brahmia B; Hilfiker S
    Biochem Soc Trans; 2023 Apr; 51(2):587-595. PubMed ID: 36929701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 signaling in neurodegeneration: two decades of progress.
    Iannotta L; Greggio E
    Essays Biochem; 2021 Dec; 65(7):859-872. PubMed ID: 34897411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.